These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21390999)

  • 1. Joint modeling of outcome, observation time, and missingness.
    Kenward MG; Rosenkranz GK
    J Biopharm Stat; 2011 Mar; 21(2):252-62. PubMed ID: 21390999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts.
    Siddiqui O; Ali MW
    J Biopharm Stat; 1998 Nov; 8(4):545-63. PubMed ID: 9855033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets.
    Siddiqui O; Hung HM; O'Neill R
    J Biopharm Stat; 2009; 19(2):227-46. PubMed ID: 19212876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
    Kong F; Chen YF; Jin K
    J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of methods for analysis of repeated binary responses with missing data.
    Frank Liu G; Zhan X
    J Biopharm Stat; 2011 May; 21(3):371-92. PubMed ID: 21442514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA.
    Mallinckrodt CH; Kaiser CJ; Watkin JG; Molenberghs G; Carroll RJ
    Clin Trials; 2004; 1(6):477-89. PubMed ID: 16279288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of practical approaches for handling missing data in clinical trials.
    DeSouza CM; Legedza AT; Sankoh AJ
    J Biopharm Stat; 2009 Nov; 19(6):1055-73. PubMed ID: 20183464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Random effects and latent processes approaches for analyzing binary longitudinal data with missingness: a comparison of approaches using opiate clinical trial data.
    Albert PS; Follmann DA
    Stat Methods Med Res; 2007 Oct; 16(5):417-39. PubMed ID: 17656452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates.
    Salim A; Mackinnon A; Christensen H; Griffiths K
    Psychiatry Res; 2008 Sep; 160(3):335-45. PubMed ID: 18718673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.
    Yang X; Shoptaw S
    Drug Alcohol Depend; 2005 Mar; 77(3):213-25. PubMed ID: 15734221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulation-based study comparing multiple imputation methods for non-monotone missing ordinal data in longitudinal settings.
    Donneau AF; Mauer M; Lambert P; Molenberghs G; Albert A
    J Biopharm Stat; 2015; 25(3):570-601. PubMed ID: 24905056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missing radiographic data handling in randomized clinical trials in rheumatoid arthritis.
    Huang X; Jiao L; Wei L; Quan H; Teoh L; Koch GG
    J Biopharm Stat; 2013; 23(6):1435-52. PubMed ID: 24138441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missing data handling in chronic pain trials.
    Kim Y
    J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF.
    Gadbury GL; Coffey CS; Allison DB
    Obes Rev; 2003 Aug; 4(3):175-84. PubMed ID: 12916818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accounting for dropout bias using mixed-effects models.
    Mallinckrodt CH; Clark WS; David SR
    J Biopharm Stat; 2001; 11(1-2):9-21. PubMed ID: 11459446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Semi-parametric and non-parametric methods for clinical trials with incomplete data.
    O'Brien PC; Zhang D; Bailey KR
    Stat Med; 2005 Feb; 24(3):341-58. PubMed ID: 15547952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of type I error rate associated with dose-group switching in a longitudinal Alzheimer trial.
    Habteab Ghebretinsae A; Molenberghs G; Dmitrienko A; Offen W; Sethuraman G
    J Biopharm Stat; 2014; 24(3):660-84. PubMed ID: 24697817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling missingness for time-to-event data: a case study in osteoporosis.
    Neuenschwander B; Branson M
    J Biopharm Stat; 2004 Nov; 14(4):1005-19. PubMed ID: 15587977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial imputation approach to analysis of repeated measurements with dependent drop-outs.
    Wei L; Shih WJ
    Stat Med; 2001 Apr; 20(8):1197-214. PubMed ID: 11304736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A latent variable approach in simultaneous modeling of longitudinal and dropout data in schizophrenia trials.
    Goyal N; Gomeni R
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1570-6. PubMed ID: 23602612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.